期刊
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
卷 30, 期 6, 页码 1253-U402出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.110.203364
关键词
atherosclerosis; cytokines; hemoglobin; macrophages; peripheral arterial disease
资金
- Leducq Foundation
- Ministerio de Ciencia y Tecnologia [SAF2007/60896, HF2007-0120, SAF2007/63648]
- Comunidad de Madrid [S2006/GEN-0247]
- Fondo de Investigaciones Sanitarias
- Instituto de Salud Carlos III [RD06/0014/0035]
- Ministerio de Sanidad y Consumo [RETICS RD06/0014/0035]
- La Nouvelle Societe Francaise d'Atherosclerose
- Fondation pour la Recherche Medicale
Objective-In addition to its role in the clearance of haptoglobin-hemoglobin (Hp-Hb) complexes, CD163 is a macrophage scavenger receptor for tumor necrosis factor-like weak inducer of apoptosis (TWEAK). We recently reported that the CD163/TWEAK plasma ratio could be a potential biomarker of atherothrombosis in asymptomatic subjects. In this study, we assessed soluble TWEAK (sTWEAK) and soluble CD163 (sCD163) plasma levels in white males with peripheral artery disease (PAD) and in atherothrombotic femoral plaques to evaluate their relationship with disease. We also analyzed whether Hp-Hb complexes could compete for CD163-mediated TWEAK uptake. Methods and Results-Patients with PAD (n = 155) showed a trend toward lower sTWEAK (median [interquartile range]: 134 [110-204] versus 147 [119-205] pg/mL; P = 0.067) and higher sCD163 (median [interquartile range]: 367 [269-506] versus 288 [234-369] ng/mL; P < 0.001) plasma concentrations than age-matched controls (n = 251). sCD163 and sTWEAK plasma levels were negatively correlated in both patients and controls. After stratification according to the severity of disease, sCD163/sTWEAK ratio was significantly increased in patients with more severe disease relative to the other groups (P = 0.049). Analysis of conditioned medium obtained from cultured human atherothrombotic femoral plaque samples (n = 36) and healthy aortas (n = 14) revealed that high amounts of sCD163 were released by the atherothrombotic tissue, whereas sTWEAK presented the opposite trend (P < 0.05). Finally, we report a potential association between CD163 shedding and oxidative stress. Conclusion-Our results suggest that the sCD163/sTWEAK plasma ratio may be associated with atherothrombosis burden in PAD. We hypothesize that an imbalance between TWEAK and CD163 could reflect the progression of atherothrombosis. (Arterioscler Thromb Vasc Biol. 2010; 30: 1253-1262.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据